Acura Pharmaceuticals Inc - Company Profile

Powered by

All the sales intelligence you need on Acura Pharmaceuticals Inc in one solution.

$ $295
Register your interest Learn more
  • Save hours of research time with a comprehensive
    Sales Intelligence Solution.

  • Understand how Acura Pharmaceuticals Inc fits into your total
    addressable market and Ideal Customer Profile.

  • Gain competitive edge with triggers that tell you
    when and how to engage with Acura Pharmaceuticals Inc.

Back to companies

Acura Pharmaceuticals Inc: Overview

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

Select Item

Acura Pharmaceuticals Inc (Acura) is a specialty pharmaceutical company. It researches, develops, and commercializes products and technologies to prevent the abuse and misuse of medication. Acura’s proprietary technologies include, Aversion, Limitx, and Impede technology. The company’s Limitx technology helps to minimize the risks associated with drug overdose and Aversion technology is to address methods of abuse associated with opioid analgesics. Its Impede technology helps minimize the extraction and conversion of pseudoephedrine into methamphetamine. Its product portfolio includes Oxaydo, an opioid analgesic; Nexafed and Nexafed Sinus Pressure plus that contain pseudoephedrine. The company markets products in the US and Canada. Acura is headquartered in Palatine, Illinois, the US.

 Gain a 360-degree view of Acura Pharmaceuticals Inc and make more informed decisions for your business Gain a 360-degree view of Acura Pharmaceuticals Inc and make more informed decisions for your business Learn more
Headquarters United States of America
Address 616 N. North Court, Suite 120, Palatine, Illinois, 60067
Website www.acurapharm.com
Telephone 1 847 7057709
Industry Pharmaceuticals and Healthcare
Ticker Symbol & Exchange ACUR (OTC)
Revenue (2021) $1.6M -56.2% (2021 vs 2020)
EPS XYZ
Net Income (2021) XYZ 27.2% (2021 vs 2020)
Market Cap* $60,000
Net Profit Margin (2021) XYZ 0.0% (2021 vs 2020)
   
* As of and is in US$
View Acura Pharmaceuticals Inc financials
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Learn more

Acura Pharmaceuticals Inc premium industry data and analytics

50+

Marketed Drugs

Understand Acura Pharmaceuticals Inc’s commercialized product portfolio to stay one step ahead of the market.

20+

Pipeline Drugs

Identify which of Acura Pharmaceuticals Inc’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.

13+

Clinical Trials

Determine Acura Pharmaceuticals Inc go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

2

Insights

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

1

Catalyst Calendar

Proactively evaluate Acura Pharmaceuticals Inc’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.

Image for loader
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Learn more
Executives
Name Position Board Since Age
Non Dignissim Eros Proin vel Convallis 2026 XY
Non Dignissim Eros Proin vel Convallis 2026 XY
Non Dignissim Eros Proin vel Convallis 2026 XY
Gain insight into Acura Pharmaceuticals Inc key executives to enhance your sales strategy Gain insight into Acura Pharmaceuticals Inc key executives to enhance your sales strategy Learn more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Why are you leaving?